跳至主要内容
临床试验/CTRI/2009/091/001058
CTRI/2009/091/001058已完成4 期

A COMPARATIVE STUDY TO EVALUATE EFFICACY AND SAFETY BETWEEN GABAPENTIN, PREGABALIN AND DULOXETINE IN PATIENTS WITH PAINFUL DIABETIC PERIPHERAL NEUROPATHY

Research society for the study of diabetes in India RSSDI0 个研究点目标入组 152 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
152

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Either gender with type 2 diabetes b/w 5-10 yrs duration
  • Patients with distal polyneuropathy by history, examination, biothesiometry & Michigan Neuropathy Screening Instrument (MNSI)
  • Diabetic neuropathy (DN) for at least 3 months
  • Patients above 18 and below 65 years
  • HbA1C < 10
  • Minimum VAS score for pain of 40 mm
  • Patients with written informed consent

排除标准

  • Contraindications for the use of study drugs.
  • Hepatic, cardiac or renal failure
  • Patients with neuropathy due to other causes.
  • Patients who have undergone amputations of even one lower limb.
  • Pregnant and lactating women.

研究者

发起方
Research society for the study of diabetes in India RSSDI

相似试验